Reports: Novartis no longer pursuing Gen-Probe

Novartis is reportedly no longer looking into buying diagnostic test maker Gen-Probe, the Wall Street Journal says, citing sources. Life Technologies and Thermo Fisher Scientific had also expressed interest in the company, but dropped their pursuits last month. News

Suggested Articles

In an SEC filing, Baxter International disclosed that it may have overstated its income over multiple years, inflating it by about $276 million.

The FDA has given Grail a green light to conduct the interventional study, and it has begun enrolling participants through the company’s R&D partners.

Coronavirus may not require a front-line battle yet in certain places, but it’s still taxing public health officials preparing for a potential crisis.